Nippon Life Global Investors Americas Inc. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 11.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 115,290 shares of the healthcare conglomerate's stock after purchasing an additional 11,540 shares during the quarter. UnitedHealth Group accounts for approximately 3.0% of Nippon Life Global Investors Americas Inc.'s portfolio, making the stock its 9th largest holding. Nippon Life Global Investors Americas Inc.'s holdings in UnitedHealth Group were worth $60,383,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Bayforest Capital Ltd lifted its position in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its holdings in UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Copia Wealth Management purchased a new position in UnitedHealth Group in the 4th quarter valued at $42,000. IAG Wealth Partners LLC purchased a new position in UnitedHealth Group in the 1st quarter valued at $42,000. Finally, Investment Management Corp VA ADV purchased a new position in UnitedHealth Group in the 4th quarter valued at $44,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms have recently commented on UNH. Bank of America lifted their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Morgan Stanley reduced their price target on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating on the stock in a report on Wednesday, August 20th. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Barclays raised their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research report on Thursday. Finally, Truist Financial cut their price objective on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research report on Wednesday, July 16th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $354.86.
View Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group Stock Up 1.6%
UNH stock traded up $5.07 during trading on Monday, hitting $320.46. 17,541,354 shares of the company's stock were exchanged, compared to its average volume of 12,809,192. The business has a 50-day moving average price of $288.78 and a two-hundred day moving average price of $372.56. The stock has a market capitalization of $290.23 billion, a price-to-earnings ratio of 13.88, a PEG ratio of 2.04 and a beta of 0.44. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the firm posted $6.80 EPS. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is 38.30%.
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.28% of the stock is owned by company insiders.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.